(Q37345911)

19 August 2017

1 reference

title

Treatment options for hepatocellular carcinoma (English)

1 reference

19 August 2017

Lewis R Roberts

4

0 references

author name string

Dalbir S Sandhu

series ordinal

1

1 reference

19 August 2017

Vivek S Tharayil

series ordinal

2

1 reference

19 August 2017

Jin-Ping Lai

series ordinal

3

1 reference

19 August 2017

1 February 2008

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

1

1 reference

19 August 2017

81-92

1 reference

Global cancer statistics in the year 2000.

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Relationship between hepatocellular carcinoma and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Epidemiology and clinical presentation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Hepatocellular carcinoma: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Treatment options for hepatobiliary and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Induction of remission in hepatocellular carcinoma with doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Systemic therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Clinical trials in primary hepatocellular carcinoma: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Octreotide therapy for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Immunotherapeutic strategies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Gene- and immunotherapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Molecular pathways and related target therapies in liver carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Unresectable Hepatocellular Carcinoma: Meta-Analysis of Arterial Embolization [letter]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.1.81

21 January 2018

Identifiers

DOI

10.1586/17474124.2.1.81

1 reference

release_htgcu3k5ubgvnjqxhvedkteyea

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/htgcu3k5ubgvnjqxhvedkteyea

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference